Deadline: Friday, 30 November, 2018 by 17:00
The Research, Innovation and Development Trust (RIDT) of the University of Malta has funds available, through the ALIVE Charity Foundation, to support cancer research. The total amount available for disbursement is €240,000.
Our goal is to support research that might in future help reduce the incidence of cancer, improve cancer survival and the quality of life of cancer patients. We will award grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer.
The call is open to any Resident Academic of the University of Malta. Applicants may only receive one grant under this specific call.
Projects that are either already completed, are on course or are due to start before the application deadline cannot b
e considered for funding under this scheme.
Projects can have a maximum duration of 36 months from the date of the award. Each awarded projects can receive a maximum of €60,000 for the completion of the study. Awards will take into consideration the relevance of the work proposed and the quality of work to be anticipated.
Proposals are to be received at:
University of Malta Valletta Campus
St Paul Street
or by email to email@example.com
by not later than 30 November 2018.
All applications will be acknowledged by email.
The University of Malta Research Innovation and Development Trust (‘RIDT’) was established by the Government of Malta in 2011 as an integral component of Malta’s established policy to bolster investment in research and development on a national level.
It is intended to attract funds from private and corporate bodies to be used to maximise and exploit the research milieu at the University of Malta.
It is envisaged that by encouraging high-calibre research through the fund, the University of Malta will foster the commercial exploitation of research and facilitate its industrial use.